Vectura News

Discover more about our company, science, innovation and people with the latest headlines from Vectura.

Displaying 12 of 64

Vectura wins Mediscience’s Best Communication Award

Published17/11/2021

Read more
Our CDMO expertise in the spotlight

Published24/08/2021

Read more
Vectura at CPhI North America 2021: July 26 – August 6

Published26/07/2021

Read more
Vectura Signs Pre-Clinical Development Agreement with Incannex to Advance IHL-216A for the Treatment of Traumatic Brain Injury

Published22/06/2021

Read more
Shortlisted for Best Sustainability Reporting: Healthcare

Published15/06/2021

Read more
Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production SAS

Published10/06/2021

Read more
Vectura at BIO Digital, June 10-11 & 14-18, 2021

Published09/06/2021

Read more
Vectura and Inspira Pharmaceuticals Sign Agreement to Develop Potential Inhaled Treatment for COVID-19

Published06/05/2021

Read more
Showcasing our scientific expertise at Respiratory Drug Delivery Congress (RDD) 4th-7th May, 2021

Published28/04/2021

Read more
Vectura highlights update made by Hikma on launch of generic Advair Diskus®

Published21/04/2021

Read more
“Strategies for rapid progression of inhaled products” at Formulation & Delivery Europe Congress: Online

Published15/04/2021

Read more
Will Downie named in The Medicine Maker’s Power List for 2021

Published15/04/2021

Read more
1 2 3 6

Displaying 12 of 64